The Supreme Court has extended a temporary freeze on new restrictions for the abortion pill mifepristone, allowing its continued mail-order prescribing. This extension provides a temporary relief for pharmacies and telehealth companies involved in dispensing the drug. The court's action comes amid a legal challenge from anti-abortion advocates seeking to roll back expanded access to mifepristone, which was previously supported by a Biden administration policy. AI
Summary written by gemini-2.5-flash-lite from 2 sources. How we write summaries →
RANK_REASON Supreme Court action on a significant drug policy. [lever_c_demoted from significant: ic=2 ai=0.0]